Clearing the Gridlock in High-Cost Drug Authorizations

Elite PA 360° is a specialty prior authorization concierge that mitigates clinical and financial risk for high-cost therapies--where delays, denials & missteps carry six- & seven-figure consequences.

Focused expertise for oncology, biologics, infusion, & specialty medications exceeding $10k per dose.

Request the Practice Overview

More than 200 satisfied physician practices & infusion centers

THE STAKES

When Authorizations Stall, Everything Else Follows

In specialty care, prior authorization is not an administrative step--it is a critical control point. A single delay or denial can disrupt treatment timelines, compromise patient adherence, & place significant revenue at risk.

🧠 Clinical Intelligence

⚡ Strategic Workflow

Most practices are not failing due to lack of effort. They are constrained by fragmented workflows, inconsistent payer interpretation, & staffing models that were never designed for high-cost, high complexity therapies.

Elite PA 360° exists to absorb that risk--before it becomes clinical fallout or financial loss.

The Elite PA 360° Difference

This Is Not Volume Processing. This is Risk Management.

Financial Risk Containment

1. We protect therapies exceeding $10K per dose by preventing avoidable denials, rework, & therapy abandonment tied to authorization failure.

Clinical Intelligence at Submission

2. Every authorization is guided by payer policy analysis, documentation strategy, & therapy sequencing--not generic checklists or automation alone.

Accountability Through Resolution

3. We do not disengage when an authorization stalls. We remain involved through escalation, appeal, or final determination.

HOW WE WORK

Structured. Controlled. Outcome-Driven.

Elite PA 360° operates under defined engagement thresholds to ensure depth, continuity, & accountability. Our services are structured around:

  • High-cost new starts

  • Dose changes & renewals

  • Appeals & step-therapy navigation

  • Backlog stabilization during operational strain

We work with a limited number of practices to maintain precision--not volume.

RESULTS

The Results Speak for Themselves:

  • 90%+ authorization approval success rate across specialty therapies

  • 📉 Measurable reduction (40%) in avoidable denials and rework

  • ⏱️ Turnaround times reduced from weeks to days

  • Improved therapy initiation consistency

Our role is not to submit prior authorizations.

Our role is to prevent treatment disruption at the most exposed moments of care.

Request a Practice Overview